Hughes syndrome: The antiphospholipid syndrome

Journal of the Royal College of Physicians of London

Volumn 32, Issue 3, 1998, Pages 260-264

  Hughes, Graham R V ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; HEPARIN; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY; PHOSPHOLIPID BINDING PROTEIN; WARFARIN;

ANTIPHOSPHOLIPID SYNDROME; AVASCULAR NECROSIS; BLEEDING; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; INTRACARDIAC THROMBOSIS; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY DISEASE; LIVER DISEASE; OCCLUSIVE CEREBROVASCULAR DISEASE; PATHOGENESIS; PREGNANCY COMPLICATION; PULMONARY HYPERTENSION; REVIEW; SPONTANEOUS ABORTION; SYNDROME DELINEATION; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS; VALVULAR HEART DISEASE; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; ASPIRIN; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEPARIN; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; PREGNANCY; PREGNANCY COMPLICATIONS; RETROSPECTIVE STUDIES;

EID: 0031833822     PISSN: 00358819     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Khamashta MA, Mackworth-Young C. Antiphospholipid (Hughes) syndrome. A treatable cause of recurrent pregnancy loss. Br Med J 1997;314:244.
2. Wilson WA, Hughes GRV. Aetiology of Jamaica neuropathy (letter). Lancet 1975;i:345.
3. Hughes GRV. Thrombosis, abortion, cerebral disease and lupus anticoagulant. Br Med J 1983;287:1088-9.
4. Derue GJ, Englert HJ, Harris EN, Gharavi AE, et al. Fetal loss in systemic lupus: association with anticardiolipin antibodies. J Obstet Gynaecol 1985;5:207-9.
5. Harris EN, Chan JKH, Asherson RA, Hughes GRV. Thrombosis, recurrent fetal loss and thrombocytopenia: predictive value of the anticardiolipin test. Arch Intern Med 1986;146:2153-6.
6. Hughes GRV. Connective tissue disease and the skin. Clin Exp Dermatol 1984;9:535-44.
7. Hughes GRV, Asherson RA. Formes atypiques du lupus érythemateux disseminé. In: Crosnier J, Funck-Bretano JL, Brack JF, Grunfeld JP (eds). Actualités nécrologiques. Paris: Flammarion Médicine, 1984.
8. Harris EN, Gharavi AE, Asherson RA, Boey ML, Hughes GRV. Cerebral infarction in SLE. Association with anticardiolipin antibodies. Clin Exp Rheumatol 1984;2:47-51.
9. Mackworth-Young CG, Gharavi AE, Boey ML, Hughes GRV. Portal and pulmonary hypertension in a case of SLE: possible relationships with clotting abnormality. Eur J Rheumatol Inflam 1984;7:71-4.
10. Asherson RA, Mackworth-Young CG, Boey ML, Hughes GRV. Pulmonary hypertension in SLE. Br Med J 1983;287:1024-5.
11. Asherson RA, Mackworth-Young CG, Boey ML, Harris EN, Hughes GRV. Pulmonary hypertension in SLE: a report of 3 cases. J Rheumatol 1986;13:416-8.
12. Harris EN, Gharavi AE, Mackworth-Young CG, Patel BM, et al. Lupoid sclerosis: a possible pathogenetic role for antiphospholipid antibodies. Ann Rheum Dis 1985;44:281-2.
13. Asherson RA, Hughes GRV. Antiphospholipid antibodies and chorea. J Rheumatol 1987;15:377-9.
14. Asherson RA, Derksen R, Harris EN, Hughes GRV. Chorea in systemic lupus and lupus-like disease: association with antiphospholipid antibodies. Sem Arth Rheum 1987;16:253-9.
15. Asherson RA, Morgan SH, Harris EN, Gharavi AE, et al. Arterial occlusion causing large bowel infarction - a reflection of clotting diathesis in SLE. Clin Rheumatol 1986;5:102-6.
16. Harris EN, Gharavi AE, Hegdi U, Hughes GRV. Anticardiolipin antibodies in autoimmune thrombocytopenia purpura. Br J Haematol 1985;59:231-4.
17. Asherson RA, Mercy D, Phillips G. Recurrent stroke and multi-infarct dementia in SLE associated with antiphospholipid antibodies. Ann Rheum Dis 1987;46:605-11.
18. Hughes GRV. The antiphospholipid syndrome: ten years on. Lancet 1993;342:341-4.
19. Harris EN, Englert H, Derue G, Hughes GRV. Antiphospholipid antibodies in acute Guillain-Barré syndrome. Lancet 1983;ii:1361-2.
20. Herranz MT, Rivier G, Khamashta MA, Mackworth-Young CG, et al. Association between antiphospholipid antibodies and epilepsy in patients with SLE. Arth Rheum 1994;37:568-71.
21. Khamashta MA, Cervera R, Asherson RA, Font J, et al. Association of antibodies against phospholipids with heart valve disease in SLE. Lancet 1990;335:1541-2.
22. Asherson RA, Hughes GRV. Addison's disease and primary antiphospholipid syndrome. Lancet 1989;ii:874-5.
23. Harris EN, Gharavi AE, Boey ML, Patel BM, et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in SLE. Lancet 1983;ii:1211-4.
24. Gharavi AE, Harris EN, Asherson RA, Hughes GRV. Isotype distribution and phospholipid specificity in antiphospholipid syndrome. Ann Rheum Dis 1987;46:461-6.
25. Harris EN, Gharavi AE, Hughes GRV. Anticardiolipin antibody testing: the need for standardisation. Arth Rheum 1987;30:835-6.
26. Harris EN, Gharavi AE, Patel SP, Hughes GRV. Evaluation of the anticardiolipin antibody test: report of a standardisation workshop held on April 4, 1986. Clin Exp Immunol 1987;68:215-22.
27. Hughes GRV. The anticardiolipin syndrome. Clin Exp Rheumatol 1985;3:285-7.
28. Harris EN, Hughes GRV, Gharavi AE. The antiphospholipid antibody syndrome. J Rheumatol 1987;13(Suppl):210-11.
29. Mackworth-Young CG, David J, Loizou S, Walport MJ. Primary antiphospholipid syndrome: features in patients with mixed anticardiolipin antibodies and no other disorder. Br J Rheumatol 1987;26(Suppl 2):94.
30. Asherson RA, Khamashta MA, Ordi-Ros J, Derksen R, et al. The 'primary' antiphospholipid syndrome: major clinical and serological features. Medicine (Baltimore) 1989;68:366-74.
31. Alarcon-Segovia D, Deleze M, Oria CV, Sanchez-Guerrero J, Gomez Pachaco L. Antiphospholipid antibodies and the antiphospholipid syndrome in SLE. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 1989;68:353-6.
32. Galli M, Confurius P, Maassen C, Hemker HC, et al. Anticardiolipin antibodies are directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990;335:1544-7
33. McNeil HP, Simpson RJ, Chesterman CN, Krilis SA. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: B2 glycoprotein 1. Proc Natl Acad Sci 1990;87:4120-4.
34. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koika T. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990;336:177-8.
35. Kandiah DA, Sheng YH, Krilis SA. B2-glycoprotein 1: target antigen for autoantibodies in the 'antiphospholipid syndrome'. LUPUS 1996;5:381-5.
36. Amengual O, Atsumi T, Khamashta MA, Koike T, Hughes GRV. Specificity of ELISA for antibody to B2 glycoprotein 1 in patients with antiphospholipid syndrome. Br J Rheumatol 1996;35:1239-43.
37. Roubey RAS. Autoantibodies to phospholipid binding proteins: a new view of lupus anticoagulants and other 'antiphospholipid' antibodies. Blood 1994;84:2854-67
38. Levine SR, Brey RL. Neurological aspects of antiphospholipid antibody syndrome. LUPUS 1996;5:347-53.
39. Hamsten A, Norberg R, Bjorkholm M. Antibodies to cardiolipins in young survivors of myocardial infarction. Lancet 1986;i:113-6.
40. Khamashta MA, Cuadrado MJ, Mujic F, Taub N, et al. The management of thrombosis in the antiphospholipid antibody syndrome. N Engl J Med 1995;332:993-7.
41. Kincaid-Smith P, Fairley KE, Kloss M. Lupus anticoagulant associated with renal thrombotic microangiopathy and pregnancy-related renal failure. Q J Med 1988;69:795-815.
42. Amigo MC, Garcia-Torres R, Robles M, Bochicchio T, Reyes PA. Renal involvement in primary antiphospholipid syndrome. J Rheumatol 1992;19:1181-5.
43. Asherson RA, Noble GR, Hughes GRV. Hypertension, renal artery stenosis and the 'primary' antiphospholipid syndrome. J Rheumatol 1991;18:1413-5.
44. Pelletier S, Landi B, Piette JC, et al. Antiphospholipid syndrome as the second cause of non-malignant Budd-Chiari syndrome. Arth Rheum 1992;35(Suppl):S238.
45. Asherson RA, Liote F, Page B, Meyer O, et al. Aseptic necrosis of bone and antiphospholipid antibodies in SLE. J Rheumatol 1993; 20:284-8.
46. Asherson RA, Piette JC. The catastrophic antiphospholipid syndrome in 1996: acute multi-organ failure associated with antiphospholipid antibodies: a review of 31 patients. LUPUS 1996;5:414-7.
47. Wilson WA, Gharavi AE. Genetic risk factors for aPL syndrome. LUPUS 1996;5:398-403.
48. Krause I, Blank M, Shoenfeld Y. Immunomodulation of experimental APS: lessons from murine models. LUPUS 1996;5:458-62.
49. Pierangeli SS, Harris EN. In vivo models of thrombosis for the antiphospholipid syndrome. LUPUS 1996;5:451-5.
50. Ames PRJ, Khamashta MA, Hughes GRV. Antiphospholipid antibodies. In: Schur PH (ed). The clinical management of SLE. Boston: Lippincott Raven, 1996:211-24.
51. Rai R, Cohen H, Dave M, Regan L. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies. Br Med J 1997;314:253-7
52. Shah NM, Khamashta MA, Atsumi T, Hughes GRV. Outcome of patients with anticardiolipin antibodies: ten year follow up of 52 patients. LUPUS 1998;7:3-7.
53. Vaarala O. Atherosclerosis in SLE and Hughes syndrome. LUPUS 1997;6:489-90.
54. Vaarala O. Antiphospholipid antibodies and atherosclerosis. LUPUS 1996;5:442-7.
55. Amengual O, Atsumi T, Khamashta MA, Tinahones F, Hughes GRV. Autoantibodies against oxidised low density lipoprotein in antiphospholipid syndrome. Br J Rheumatol 1997;36:964-8.
56. George J, Shoenfeld Y. The antiphospholipid (Hughes) syndrome: a crossroads of autoimmunity and atherosclerosis. LUPUS 1997;6:559-60.